Literature DB >> 2998251

Primary human T-lymphotropic virus type III infection.

D D Ho, M G Sarngadharan, L Resnick, F Dimarzoveronese, T R Rota, M S Hirsch.   

Abstract

Primary infection with the human T-lymphotropic virus type III (HTLV-III) was documented in three patients by virus isolation during acute illness and concurrent or subsequent HTLV-III seroconversion. All patients had fevers, rigors, arthralgias, and myalgias. Additional symptoms included truncal maculopapular rash, urticaria, abdominal cramps, and diarrhea. Lymphocytic meningitis accompanied the febrile illness in two patients. The estimated incubation period was 4 to 6 weeks, and the symptoms lasted 2 to 3 weeks. Seroconversion occurred 8 to 12 weeks after presumed exposure and was manifested by a characteristic antibody response pattern. Physicians should consider the possibility of primary HTLV-III infection when evaluating patients who belong to one of the risk groups for the acquired immunodeficiency syndrome and who have prolonged febrile illnesses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998251     DOI: 10.7326/0003-4819-103-6-880

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  46 in total

1.  Acute meningoencephalitis and meningitis due to primary HIV infection.

Authors:  P J Newton; W Newsholme; N S Brink; H Manji; I G Williams; R F Miller
Journal:  BMJ       Date:  2002-11-23

2.  Coalescent estimates of HIV-1 generation time in vivo.

Authors:  A G Rodrigo; E G Shpaer; E L Delwart; A K Iversen; M V Gallo; J Brojatsch; M S Hirsch; B D Walker; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 3.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10

4.  Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986.

Authors:  J S Dummer; S Erb; M K Breinig; M Ho; C R Rinaldo; P Gupta; M V Ragni; A Tzakis; L Makowka; D Van Thiel
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

5.  HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

Authors:  R S Remis; M V O'Shaughnessy; C Tsoukas; G H Growe; M T Schechter; R W Palmer; D N Lawrence
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

6.  Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.

Authors:  N Manca; F di Marzo Veronese; D D Ho; R C Gallo; M G Sarngadharan
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

7.  Neurological features in AIDS patients: studies on cerebrospinal fluid.

Authors:  L Ortona; E Tamburrini; A Antinori; G Ventura
Journal:  Ital J Neurol Sci       Date:  1988-12

Review 8.  Neurologic and psychiatric manifestations of HIV disease.

Authors:  H Hollander
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

9.  Primary HIV-I infection associated with pneumonitis.

Authors:  E L Ong; B K Mandal
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 10.  Uncommon yeastlike zoopathogens and commercial systems for their identification.

Authors:  G A Land; I F Salkin
Journal:  Mycopathologia       Date:  1987-09       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.